Evidence map›Paper›PMID 20705737›Full record

ReviewHuman molecular genetics2010

Exome sequencing: the sweet spot before whole genomes.

Jamie K Teer, James C Mullikin

Registry-linked trialAbstract readReview
In one paragraph

Review in Human molecular genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03084224 (Implementation of Molecular Diagnostic Pathways in Neurological and Neurodegenerative Diseases), which is not on this map. Cited by 155 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03084224 unknown statusnot on this mapstarted 2019, after this paper: background citation

Implementation of Molecular Diagnostic Pathways in Neurological and Neurodegenerative Diseases

Typeobservational_patient_registrySponsorNeuromed IRCCSRan2019 to 2025Enrolled1ConditionsGenetic DiseaseArmsneurological and neurodegenerative diseases
3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Copy Number Variants in Alzheimer's Disease.Journal of Alzheimer's disease : JAD · 2017
    Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Trial
  6. The impact of DNA input amount and DNA source on the performance of whole-exome sequencing in cancer epidemiology.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015
    Trial
  7. Advances in mutant characterization for detecting causal mutations in crop plants.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2026
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Functional genomics and small molecules in mitochondrial neurodevelopmental disorders.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  13. Article
  14. Review
  15. Different perspectives on translational genomics in personalized medicineJournal of the Turkish German Gynecological Association · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Integrative modeling of transmitted andQuantitative biology (Beijing, China) · 2021
    Article

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jamie K TeerGenetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, 5625 Fishers Lane, Bethesda, MD 20892, USA.
James C Mullikin

Funding

Inter- and Intra-Species Comparative SequencingZIBHG000196 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI THOMAS, JAMES · 2009 to 2025
$177.6M
Comparative Genomics Unit ResearchZIAHG200330 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI MULLIKIN, JAMES C · 2009 to 2022
$17.9M
Intramural NIH HHS
6 · The paper itself

Abstract

The development of massively parallel sequencing technologies, coupled with new massively parallel DNA enrichment technologies (genomic capture), has allowed the sequencing of targeted regions of the human genome in rapidly increasing numbers of samples. Genomic capture can target specific areas in the genome, including genes of interest and linkage regions, but this limits the study to what is already known. Exome capture allows an unbiased investigation of the complete protein-coding regions in the genome. Researchers can use exome capture to focus on a critical part of the human genome, allowing larger numbers of samples than are currently practical with whole-genome sequencing. In this review, we briefly describe some of the methodologies currently used for genomic and exome capture and highlight recent applications of this technology.

Indexed as

Chromosome MappingGenome, HumanHumansSequence Analysis, DNA

Identifiers

PMID20705737
PMCPMC2953745

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.